Both in Biotechnology
Odyssey Therapeutics vs Cullinan Therapeutics
Over the past year ODTX returned −20.7% and CGEM returned −27.0%; their daily moves had a correlation of 0.52.
ODTX −20.7% CGEM −27.0%Growth of $1, one year, split-adjusted
| Metric | ODTX | CGEM |
|---|---|---|
| Price | $19.54 | $15.03 |
| Market cap | $939.1M | $967.3M |
| Today | −1.46% | −2.72% |
| 1 month | −4.3% | +3.4% |
| 6 months | — | +11.9% |
| Year to date | — | +45.2% |
| 1 year | — | +95.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $310.6M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | — | 75.4% |
| Short % of float | 13.6% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).